Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price

Neurohumoral Modulators in Heart Failure, An Issue of Heart Failure Clinics

9781416026648
256.99 zł
231.29 zł Save 25.70 zł Tax included
Lowest price within 30 days before promotion: 231.29 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
This issue discusses the role of neruohumoral modulators in Heart Failure. The role and dosing ACE inhibitor therapy, the relevance of aldosterone antagoinsts, beta blockers, and novel neurohumoral antagonists are explored. Clinical trials and intervenional recommendations are also presented.
Product Details
Saunders
34507
9781416026648
9781416026648

Data sheet

Publication date
2005
Issue number
1
Cover
hard cover
Pages count
240
Weight (g)
612
  • 1. Neurohormonal Upregulation in Heart Failure (Francis)
    2. Neurohumoral Substrate in the Community and in Populations Susceptible to Heart Failure (Ramachandran)
    3. Role and Optimal Dosing of ACE Inhibitor Therapy (Deswal)
    4. Could Beta-Blockers Precede or
    Replace ACE-Inhibitors in Heart
    Failure? (Remme)
    5. Relevance of Aldosterone Antagonists: Is There a Need to Readjust Angiotensin Inhibition? (Pitt)
    6. Novel Neurohumoral Antagonists (Udelson)
    7. Natriuretic Peptides and Remodeling in Heart Failure (Burnett)
    8. Pharmacogenomics for Neurohormonal Intervention in Heart Failure
    (McNamara)
    9. Role of Neurohumoral Modulators in Heart Failure with Preserved Systolic Function (Gheorghiade)
    10. Neural Endopeptidase Inhibitors and Endothelin Antagonists: Why Did the Clinical Trials Not Demonstrate Beneficial Effects? (Abraham)
    11. Should Neurohormonal Intervention Be Recommended in Heart Failure Stage A? (Fonarow)
    12. ACE-Inhibitors Only, ARBs Only or Both (Young)
    13. Are There Clinically Important Differences Between Beta-Blockers in Heart Failure? (Cleland)
Comments (0)
Viewed products

  • Frequently purchased together

    No products available